AN2 Therapeutics, Inc. (ANTX): 8 insider purchases in the last two years (1 opportunistic).
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Jun 3, 2025 | Easom Eric Director, Officer | 10,000 | $1.07 | $10.7K | opportunistic |
| May 29, 2025 | FitzPatrick Margaret M Director | 8,610 | $1.18 | $10.2K | no history |
| Dec 10, 2024 | Readnour Robin Shane Director | 60,000 | $1.45 | $86.8K | no history |
| Nov 27, 2024 | Zakrzewski Joseph S Director | 2,000 | $1.40 | $2.8K | no history |
| Nov 27, 2024 | Readnour Robin Shane Director | 75,000 | $1.41 | $105.8K | no history |
| Nov 21, 2024 | Readnour Robin Shane Director | 200,000 | $1.06 | $213.0K | no history |
| Nov 20, 2024 | Zakrzewski Joseph S Director | 25,000 | $1.00 | $25.1K | no history |
| Nov 18, 2024 | Easom Eric Director, Officer | 50,000 | $1.00 | $50.0K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.